BridgeMD
New treatment option for Dry Eye Disease (DED)
Official title A Clinical Study Evaluating Licaminlimab for Dry Eye Disease
ClinicalTrials.gov ID: NCT07548632
What this study is testing
What is licaminlimab?
licaminlimab is an investigational medicine, given as an once-daily treatment applied to the skin, being studied as a potential treatment for dry eye disease (ded).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of licaminlimab as compared to vehicle in participants with Dry Eye Disease and a specific genotype.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Physician diagnosis of Dry Eye Disease in the past 6 months
- Use of over-the-counter tears
- Must agree to genotype testing Key
You likely can't join if
- \- Have a history or presence of any disorder or condition that may, in the opinion of the Investigator, likely interfere with the interpretation of...
The study team makes the final eligibility decision.
Where it's taking place
- Aliso Viejo, California, United States
- Garden Grove, California, United States
- Glendale, California, United States
- Murrieta, California, United States
- Newport Beach, California, United States
- Petaluma, California, United States
- Colorado Springs, Colorado, United States
- Delray Beach, Florida, United States
- Garner, North Carolina, United States
- Shelby, North Carolina, United States
- Cranberry Township, Pennsylvania, United States
- Erie, Pennsylvania, United States
- Memphis, Tennessee, United States
- Lynchburg, Virginia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Aliso Viejo, California, United States; Garden Grove, California, United States; Glendale, California, United States; Murrieta, California, United States; Newport Beach, California, United States; Petaluma, California, United States and 8 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.